Skip to main content

NCI Awards $9.8M to 17 Early-Detection Biomarker-Development Labs

NEW YORK, Nov. 22 (GenomeWeb News) - The National Cancer Institute has awarded $9.8 million to 17 Biomarkers Developmental Laboratories within the Early Detection Research Network, the agency announced last week.

 

Institutions that were granted the first-year funding include the Universityof Pittsburgh, FoxChaseCancerCenter, the Universityof Michigan, M.D.AndersonCancerCenter, FredHutchinsonCancerResearchCenterand JohnsHopkinsUniversity. A complete list of grantees is available here.

 

Investigators at the BDL will examine the human genome, proteome, epitome, and metabolome to identify biomarkers that can potentially serve as early detection biomarkers and markers of progression of the disease.

 

"The synergized power of DNA arrays, protein arrays and bioinformatics are being used to help decipher hundreds of thousands of leads to discover unique signatures for early cancer," said Sudhir Srivastava, the chief of the cancer biomarker research group at NCI's Division of Cancer Prevention.

 

The NCI received 68 applications to serve as Biomarker Developmental Laboratories, out of which 17 were selected for funding. The funding is the second round of five-year funding for components of the EDRN.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.